Pictet Asset Management Holding SA »

Edgewise Therapeutics shares owned by Pictet Asset Management Holding SA

Quarter-by-quarter ownership of Edgewise Therapeutics (EWTX) shares owned by Pictet Asset Management Holding SA from 13F filings

Historical chart of Pictet Asset Management Holding SA investment in Edgewise Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Edgewise Therapeutics held by Pictet Asset Management Holding SA consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Edgewise Therapeutics by Pictet Asset Management Holding SA

Quarter filed Position value Share count Share price at filing
2026-03-31 $240k 7.6k 31.50
2025-03-31 $6.7M 303k 22.00
2024-12-31 $8.0M 301k 26.70

More positions owned by Pictet Asset Management Holding SA

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Apple (AAPL)
Amazon (AMZN)
Ubs Group SHS (UBS)
Kla Corp Com New (KLAC)
Thermo Fisher Scientific (TMO)
Meta Platforms Cl A (META)
Applied Materials (AMAT)
Nextera Energy (NEE)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Ecolab (ECL)

View all positions for Pictet Asset Management Holding SA

Top funds holding Edgewise Therapeutics

OrbiMed Advisors
RA Capital Management
Paradigm Biocapital Advisors
Baker Bros. Advisors
BlackRock
Henderson Group
Novo A/S
Vanguard Group
Driehaus Capital Management
Siren
Perceptive Advisors
Vanguard Capital Management
Cormorant Asset Management
Braidwell
Morgan Stanley

View all funds holding Edgewise Therapeutics